Zobrazeno 1 - 10
of 42
pro vyhledávání: '"CONTAINING REGIMENS"'
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-12 (2023)
Abstract Objective There is a lack of standard salvage treatment options for recurrent or metastatic nasopharyngeal carcinoma (RM-NPC) that has failed platinum-containing regimens. Breakthroughs in immunotherapy have opened up new options for these p
Externí odkaz:
https://doaj.org/article/70eb9afcbe554b5fb67f2f19f698bf1d
Autor:
A. I. Gubenko, N. N. Eremenko
Publikováno v:
Регуляторные исследования и экспертиза лекарственных средств, Vol 9, Iss 1, Pp 6-13 (2019)
In 2016 the WHO Assembly defined a global strategy to combat viral hepatitis viruses, which seeks to eliminate these infections by 2030. The most important goals of this programme, adopted by 194 countries, are to reduce the incidence of viral hepati
Externí odkaz:
https://doaj.org/article/b38d2e9be253417e8ab13957237f656d
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
DRUGS. 79(2):161-171
The inability to use powerful antituberculosis drugs in an increasing number of patients seems to be the biggest threat towards global tuberculosis (TB) elimination. Simplified, shorter and preferably less toxic drug regimens are being investigated f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dris___01423::7c706dd796b7bfab4e0328e56a369610
https://research.rug.nl/en/publications/904c01b8-f360-4c12-8c0c-d8cc266cf40b
https://research.rug.nl/en/publications/904c01b8-f360-4c12-8c0c-d8cc266cf40b
Publikováno v:
Drugs
The inability to use powerful antituberculosis drugs in an increasing number of patients seems to be the biggest threat towards global tuberculosis (TB) elimination. Simplified, shorter and preferably less toxic drug regimens are being investigated f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfa11d8b4da55ea2fad0964c9b9bfb90
http://europepmc.org/articles/PMC6373389
http://europepmc.org/articles/PMC6373389
Autor:
Maria Gkotzamanidou, L. Krikoni, V.L. Souliotis, Panagiota Economopoulou, Ioannis Kotsantis, Amanda Psyrri, Georgios Papaxoinis, Maria Anastasiou
Publikováno v:
ESMO Open
Background We sought to determine whether DNA damage response (DDR)-related aberrations predict therapeutic benefit in cisplatin-treated head and neck squamous cell carcinoma (HNSCC) patients and how DDR pathways are modulated after treatment with ol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed7bf71fefc697b7129816cc19fdcebf
http://europepmc.org/articles/PMC7957155
http://europepmc.org/articles/PMC7957155
Autor:
Richard van Altena, Jan-Willem C. Alffenaar, Tjip S. van der Werf, Onno W. Akkerman, Sander P. van Rijn, Richard M. Anthony, Jos G. W. Kosterink, Wiel C M de Lange, Marlanka A Zuur, Bob Wilffert
Publikováno v:
Antimicrobial Agents and Chemotherapy, 63(2):ARTN e01489-18. AMER SOC MICROBIOLOGY
Multi-and extensively drug-resistant tuberculosis (M/XDR-TB) has become an increasing threat not only in countries where the TB burden is high but also in affluent regions, due to increased international travel and globalization. Carbapenems are earm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::613ed5a2129cd1cad79f9cf2d79c5f6d
https://hdl.handle.net/11370/3cffdc31-fa1c-4706-8b1b-0df2bf3c86a7
https://hdl.handle.net/11370/3cffdc31-fa1c-4706-8b1b-0df2bf3c86a7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Simon Tiberi, Giovanni Sotgiu, Giovanni Battista Migliori, Lia D'Ambrosio, Rosella Centis, Jan-Willem C. Alffenaar, Marie-Christine Payen
Publikováno v:
European Respiratory Journal, 51(3):1702187. EUROPEAN RESPIRATORY SOC JOURNALS LTD
Renal Fanconi syndrome reported as rare adverse event during treatment of XDR-TB with meropenem http://ow.ly/3RHG30hVsef
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f0a3b70a0525e6470404fdaa6a56ea8
https://pubmed.ncbi.nlm.nih.gov/29284688
https://pubmed.ncbi.nlm.nih.gov/29284688